87 related articles for article (PubMed ID: 21465085)
1. Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.
Fokam J; Salpini R; Santoro MM; Cento V; D'Arrigo R; Gori C; Perno CF; Colizzi V; Nanfack A; Gwom LC; Cappelli G; Takou D
Arch Virol; 2011 Jul; 156(7):1235-43. PubMed ID: 21465085
[TBL] [Abstract][Full Text] [Related]
2. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
[TBL] [Abstract][Full Text] [Related]
3. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
[TBL] [Abstract][Full Text] [Related]
5. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon.
Torimiro JN; D'Arrigo R; Takou D; Nanfack A; Pizzi D; Ngong I; Carr JK; Joseph FP; Perno CF; Cappelli G
New Microbiol; 2009 Oct; 32(4):325-31. PubMed ID: 20128438
[TBL] [Abstract][Full Text] [Related]
7. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
[TBL] [Abstract][Full Text] [Related]
8. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
[TBL] [Abstract][Full Text] [Related]
10. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.
Yahi N; Fantini J; Tourres C; Tivoli N; Koch N; Tamalet C
J Infect Dis; 2001 May; 183(9):1311-7. PubMed ID: 11294661
[TBL] [Abstract][Full Text] [Related]
11. Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.
Monno L; Scudeller L; Brindicci G; Saracino A; Punzi G; Chirianni A; Lagioia A; Ladisa N; Lo Caputo S; Angarano G
Antiviral Res; 2009 Aug; 83(2):118-26. PubMed ID: 19549585
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
14. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
15. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
Ziemniak C; George-Agwu A; Moss WJ; Ray SC; Persaud D
J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
[TBL] [Abstract][Full Text] [Related]
16. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 drug resistance surveillance using dried whole blood spots.
Bertagnolio S; Soto-Ramirez L; Pilon R; Rodriguez R; Viveros M; Fuentes L; Harrigan PR; Mo T; Sutherland D; Sandstrom P
Antivir Ther; 2007; 12(1):107-13. PubMed ID: 17503754
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of HIV type 1 in Mexico: emergence of BG and BF intersubtype recombinants.
Vázquez-Valls E; Escoto-Delgadillo M; López-Márquez FC; Castillero-Manzano M; Echegaray-Guerrero E; Bitzer-Quintero OK; Kobayashi-Gutiérrez A; Torres-Mendoza BM
AIDS Res Hum Retroviruses; 2010 Jul; 26(7):777-81. PubMed ID: 20624071
[TBL] [Abstract][Full Text] [Related]
19. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
[TBL] [Abstract][Full Text] [Related]
20. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
